C
Amneal Pharmaceuticals, Inc. AMRX
$10.48 $0.121.16% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Revenue 9.81% 13.42% 16.73% 12.32% 12.37%
Total Other Revenue -- -- -- -- --
Total Revenue 9.81% 13.42% 16.73% 12.32% 12.37%
Cost of Revenue 7.86% 13.64% 16.26% 11.30% 10.90%
Gross Profit 13.23% 13.05% 17.55% 14.14% 15.07%
SG&A Expenses 8.62% 9.53% 10.88% 8.02% 10.04%
Depreciation & Amortization -- -- -- -- --
Other Operating Expenses -3,060.69% -2,853.76% 108.79% 103.84% 104.33%
Total Operating Expenses 9.00% 12.77% 15.24% 11.01% 9.78%
Operating Income 15.40% 18.03% 28.33% 22.30% 34.26%
Income Before Tax 177.24% 154.52% -36.61% -446.56% -883.39%
Income Tax Expenses 116.47% 83.46% 123.18% 822.52% 414.37%
Earnings from Continuing Operations 138.47% 126.95% -51.63% -477.87% -1,274.52%
Earnings from Discontinued Operations -- -- -- -- --
Extraordinary Item & Accounting Change -- -- -- -- --
Minority Interest in Earnings -15.58% 6.03% -21.94% -33.53% -209.31%
Net Income 101.93% 92.27% -39.16% -1,886.83% -8,426.17%
EBIT 15.40% 18.03% 28.33% 22.30% 34.26%
EBITDA 12.77% 13.01% 16.71% 10.84% 14.76%
EPS Basic 101.59% 92.50% -22.41% -1,134.95% -4,181.38%
Normalized Basic EPS -26.91% -581.91% -291.34% -92.37% -87.58%
EPS Diluted 101.34% 92.56% -20.20% -1,311.84% -2,572.65%
Normalized Diluted EPS -40.36% -591.58% -290.84% -92.37% -87.59%
Average Basic Shares Outstanding 22.67% 44.32% 75.61% 91.28% 66.63%
Average Diluted Shares Outstanding 22.94% 45.85% 75.36% 90.82% 68.83%
Dividend Per Share -- -- -- -- --
Payout Ratio -- -- -- -- --